Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3322744 | 0.85 | TSHR (0.39) | TSHRALDH1A1MGAMGAASI | |
| SCHEMBL4272897 | 0.84 | — | — | |
| SCHEMBL28956046 | 0.82 | — | — | |
| SCHEMBL4269615 | 0.76 | — | — | |
| SCHEMBL25427462 | 0.73 | — | — | |
| SCHEMBL10372938 | 0.67 | — | — | |
| SCHEMBL6432913 | 0.67 | — | — | |
| SCHEMBL780083 | 0.67 | — | — | |
| SCHEMBL1094115 | 0.64 | — | — | |
| SCHEMBL2860817 | 0.64 | TSHR (0.33) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2139904-B1 | METHOD FOR THE PRODUCTION OF AN ALKENYL PHOSPHONIC ACID DERIVATIVE | BASF SE (DE) | 2013-10-16 | — | — | EP | disclosed |
| US-8318968-B2 | Process for preparing an alkenylphosphonic acid derivative | BASF SE (DE) | 2012-11-27 | — | — | US | disclosed |
| US-20100121092-A1 | PROCESS FOR PREPARING AN ALKENYLPHOSPHONIC ACID DERIVATIVE | BASF SE (DE) | 2010-05-13 | — | — | US | disclosed |
| US-7399876-B2 | Preparation of an alkenylphosphonic acid derivative | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-15 | — | — | US | disclosed |
| US-7265242-B2 | Process for the carbonylation of ethylenically or acetylenically unsaturated compounds | SHELL OIL COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| US-20060235241-A1 | Process for the carbonylation of a conuugated diene | SHELL OIL COMPANY | 2006-10-19 | — | — | US | disclosed |
| EP-1330309-B1 | CATALYST SYSTEM AND METHOD FOR CARBONYLATION | BASF AG (DE) | 2006-04-05 | — | — | EP | disclosed |
| US-20050192457-A1 | Process for the carbonylation of ethylenically or acetylenically unsaturated compounds | SHELL OIL COMPANY | 2005-09-01 | — | — | US | disclosed |
| US-6916954-B2 | Catalyst system and method for carbonylation | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-12 | — | — | US | disclosed |
| US-20050113593-A1 | Preparation of an alkenylphosphonic acid derivative | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-26 | — | — | US | disclosed |
| US-20050113602-A1 | Preparation of an alkenylphosphonic acid derivative | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-26 | — | — | US | disclosed |
| EP-1528065-A1 | Process for the preparation of an alkenyl phosphonic acid derivative | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-04 | — | — | EP | disclosed |
| EP-1528064-A1 | Process for the preparation of an alkenyl phosphonic acid derivative | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-04 | — | — | EP | disclosed |
| EP-1203773-B1 | Process for the preparation of alkenylphosphonic acid derivatives | BASF AG (DE) | 2004-08-11 | — | — | EP | disclosed |
| US-6723882-B2 | Preparation of dialkyl ketones | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-20 | — | — | US | disclosed |
| US-20030191339-A1 | Catalyst system and method for carbonylation | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-09 | — | — | US | disclosed |
| US-20030069450-A1 | Preparation of dialkyl ketones | BASF AKTIENGESELLSCHAFT (DE) | 2003-04-10 | — | — | US | disclosed |
| US-6534669-B2 | Reacting phosphonic acid derivatives with alkynes in the presence of a metal complex catalyst system comprising nickel and a phosphine having at least two trivalent phosphorus atoms to obtain akenylphosphonic acid compound | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-18 | — | — | US | disclosed |
| US-20020077494-A1 | Preparation of alkenylphosphonic acid derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2002-06-20 | — | — | US | disclosed |
| EP-1203773-A1 | Process for the preparation of alkenylphosphonic acid derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113602-A1 | Preparation of an alkenylphosphonic acid derivative | ALK, PHOSPHO1, INPP5B | TSHR 3102/4885ALDH1A1 4323/4885MGAM 2162/4885 |
| US-20050192457-A1 | Process for the carbonylation of ethylenically or acetylenically unsaturated compounds | C5, C9, CBR1 | TSHR 2678/4885ALDH1A1 322/4885MGAM 4882/4885 |
| US-20020077494-A1 | Preparation of alkenylphosphonic acid derivatives | PHOSPHO1, INPP5B, ALK | TSHR 3226/4885ALDH1A1 3941/4885MGAM 2687/4885 |
| US-20050113593-A1 | Preparation of an alkenylphosphonic acid derivative | ALK, PHOSPHO1, INPP5B | TSHR 3307/4885ALDH1A1 4177/4885MGAM 2262/4885 |
| US-20030069450-A1 | Preparation of dialkyl ketones | PDK2, PDK3, PDK4 | TSHR 2785/4885ALDH1A1 2340/4885MGAM 2257/4885 |
| US-20100121092-A1 | PROCESS FOR PREPARING AN ALKENYLPHOSPHONIC ACID DERIVATIVE | ALK, PHOSPHO1, PRKD1 | TSHR 2853/4885ALDH1A1 1114/4885MGAM 1601/4885 |
| US-20030191339-A1 | Catalyst system and method for carbonylation | CBR3, PCCA, CBR1 | TSHR 4808/4885ALDH1A1 701/4885MGAM 3104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.